Enough experimenting! The KIT spinoff GoSilico enables the biopharmaceuticals branch to introduce the computer-supported development of manufacturing processes for new agents.
The way from the discovery of a promising agent to its authorisation is tedious. It involves countless experiments that not only cause high costs but also require a considerable amount of perseverance. “It can take up to ten years for a drug to enter the market,” says Dr Thiemo Huuk. This is a shortcoming that he tends to address together with his co-founders Prof Dr Jürgen Hubbuch, Dr Teresa Beck and Dr Tobias Hahn.
The founders of GoSilico (left to right): Dr. Thiemo Huuk, Dr. Tobias Hahn and Dr. Teresa Beck (Source: Foto Fabry)
On March 10, 2015, the accelerator program “upCAT” of the KIT Founders Forge ended in applause on the final Demo Day. After twelve weeks of intensive work, the six participating teams presented their business model to an expert audience consisting of business angels, venture capitalists, and Karlsruhe network partners. Six entirely different teams participated in the upCAT #3:
- ChromX: Software for chromatography modeling for process development and robustness studies for the biopharmaceutical industry
- LehrWerk: Construction kits as teaching materials for prospective engineers and technicians
- Paralution: Software and consulting to accelerate the calculation of computer-supported simulation
- Softtop: Weatherproof covering for bicycles and e-bikes
- Storrays: Technology for manufacturing ultra-high density peptide arrays
- tego energy: Energy supply modules for energy harvesting